Goldman Sachs’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8M | Sell |
228,204
-73,514
| -24% | -$7.67M | ﹤0.01% | 1663 |
|
|
2025
Q1 | $35.2M | Buy |
301,718
+84,151
| +39% | +$9.81M | 0.01% | 1279 |
|
|
2024
Q4 | $18.4M | Sell |
217,567
-145,058
| -40% | -$12.3M | ﹤0.01% | 1842 |
|
|
2024
Q3 | $32.6M | Sell |
362,625
-38,702
| -10% | -$3.48M | 0.01% | 1368 |
|
|
2024
Q2 | $32.3M | Buy |
401,327
+109,715
| +38% | +$8.83M | 0.01% | 1250 |
|
|
2024
Q1 | $23.3M | Buy |
291,612
+85,797
| +42% | +$6.85M | ﹤0.01% | 1439 |
|
|
2023
Q4 | $16.4M | Buy |
205,815
+46,566
| +29% | +$3.71M | ﹤0.01% | 1721 |
|
|
2023
Q3 | $11.1M | Buy |
159,249
+19,310
| +14% | +$1.35M | ﹤0.01% | 1910 |
|
|
2023
Q2 | $10.1M | Sell |
139,939
-129,381
| -48% | -$9.3M | ﹤0.01% | 2038 |
|
|
2023
Q1 | $16.6M | Buy |
269,320
+3,481
| +1% | +$215K | ﹤0.01% | 1657 |
|
|
2022
Q4 | $20.5M | Sell |
265,839
-253,425
| -49% | -$19.5M | 0.01% | 1597 |
|
|
2022
Q3 | $23.2M | Buy |
519,264
+141,927
| +38% | +$6.33M | 0.01% | 1496 |
|
|
2022
Q2 | $14.5M | Buy |
377,337
+319,200
| +549% | +$12.2M | ﹤0.01% | 1847 |
|
|
2022
Q1 | $2.41M | Sell |
58,137
-21,913
| -27% | -$907K | ﹤0.01% | 3440 |
|
|
2021
Q4 | $3.02M | Buy |
80,050
+36,341
| +83% | +$1.37M | ﹤0.01% | 3183 |
|
|
2021
Q3 | $1.44M | Buy |
43,709
+1,681
| +4% | +$55.4K | ﹤0.01% | 3729 |
|
|
2021
Q2 | $2.84M | Sell |
42,028
-100,662
| -71% | -$6.79M | ﹤0.01% | 3227 |
|
|
2021
Q1 | $8.08M | Sell |
142,690
-35,106
| -20% | -$1.99M | ﹤0.01% | 2343 |
|
|
2020
Q4 | $14.5M | Sell |
177,796
-152,661
| -46% | -$12.4M | ﹤0.01% | 1798 |
|
|
2020
Q3 | $23.5M | Sell |
330,457
-85,753
| -21% | -$6.11M | 0.01% | 1370 |
|
|
2020
Q2 | $34.2M | Buy |
416,210
+196,203
| +89% | +$16.1M | 0.01% | 1115 |
|
|
2020
Q1 | $12.9M | Buy |
220,007
+16,199
| +8% | +$953K | ﹤0.01% | 1629 |
|
|
2019
Q4 | $21.1M | Buy |
203,808
+173,588
| +574% | +$17.9M | 0.01% | 1569 |
|
|
2019
Q3 | $612K | Buy |
30,220
+8,228
| +37% | +$167K | ﹤0.01% | 3503 |
|
|
2019
Q2 | $566K | Sell |
21,992
-46,061
| -68% | -$1.19M | ﹤0.01% | 3469 |
|
|
2019
Q1 | $968K | Buy |
+68,053
| New | +$968K | ﹤0.01% | 3272 |
|
|
2018
Q1 | – | Sell |
-42,473
| Closed | -$238K | – | 4191 |
|
|
2017
Q4 | $238K | Buy |
+42,473
| New | +$238K | ﹤0.01% | 3754 |
|
|
2017
Q3 | – | Sell |
-67,618
| Closed | -$372K | – | 4271 |
|
|
2017
Q2 | $372K | Buy |
67,618
+36,698
| +119% | +$202K | ﹤0.01% | 3683 |
|
|
2017
Q1 | $121K | Buy |
+30,920
| New | +$121K | ﹤0.01% | 4074 |
|
|
2016
Q3 | – | Sell |
-17,854
| Closed | -$135K | – | 4537 |
|
|
2016
Q2 | $135K | Buy |
+17,854
| New | +$135K | ﹤0.01% | 4021 |
|
|
2016
Q1 | – | Sell |
-24,426
| Closed | -$226K | – | 4486 |
|
|
2015
Q4 | $226K | Buy |
+24,426
| New | +$226K | ﹤0.01% | 3665 |
|